MEGHAN SPINDLER: Open Payments
NPI 1497418222 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$281 in 12 payments from 8 companies in 2025. Trend: 2023 $276 · 2024 $771 · 2025 $281
Food & beverage: $281
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Inspire Medical Systems, Inc. | 1 | $37 |
| ABBVIE INC. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| GENZYME CORPORATION | 1 | $18 |
| PFIZER INC. | 1 | $17 |
Products named: NUCALA, AIRSUPRA, DUPIXENT, INSPIRE, TEFLARO, PANZYGA.
Industry payments across MD — which companies pay providers there.
